Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.
Tan L, Sandhu S, Lee RJ, Li J, Callahan J, Ftouni S, Dhomen N, Middlehurst P, Wallace A, Raleigh J, Hatzimihalis A, Henderson MA, Shackleton M, Haydon A, Mar V, Gyorki DE, Oudit D, Dawson MA, Hicks RJ, Lorigan P, McArthur GA, Marais R, Wong SQ, Dawson SJ.
Tan L, et al. Among authors: middlehurst p.
Ann Oncol. 2019 May 1;30(5):804-814. doi: 10.1093/annonc/mdz048.
Ann Oncol. 2019.
PMID: 30838379
Free PMC article.